mCRPC and BET inhibitors

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BKC

Rank: Treasurer [?]

Points: 599 [?]

Votes: 19 Score: 4.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

mCRPC and BET inhibitors

posted on Jan 26, 2016 03:28PM

Judging from this very recent paper, there is some indpendent support for the hypothesis put forward by Zenith.

http://intl-mcr.aacrjournals.org/content/early/2016/01/20/1541-7786.MCR-15-0472.abstract

Br.

BKC

5 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply